Scientists studying addiction have also turned their attention to GLP-1 medications
It received FDA approval in 2017 for type 2 diabetes (as Ozempic) and in 2021 for chronic weight management (as Wegovy), with an oral diabetes formulation (Rybelsus) also available
Peripheral artery disease (PAD) Patients who struggle with PAD can look forward to potentially expanded uses of GLP1s for improving symptoms
A branded product (Geref) was previously marketed in the U.S
They are distributed in the median wedge, anteriorly and laterally, and posteriorly adjacent to the pars nervosa
Moreover, GLP-1R has not yet been identified on human myocardial cells, negating any direct effects of GLP-1RAs on myocardial cells.470 Recently, studies have shown that the GLP-1RA Meg peptide also enters the ejection fraction reserve following heart failure therapy